choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Novavax Competitors

Novavax Competitors Newsletter
  • Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript 29 Feb 2024 15:45 GMT

    … Call Transcript February 28, 2024 Novavax, Inc. misses on earnings … morning and welcome to Novavax Fourth Quarter 2023 Financial … relating to the future of Novavax, its key strategic priorities … We also know the competitors are talking about timelines which …

  • Novavax Q4 Revenue and Earnings Miss Estimates, Stock Drops Over 25% 28 Feb 2024 20:28 GMT

    … Like other vaccine makers, Novavax’s COVID-19 products … -dose vials over competitors’ prefilled syringes. Novavax will now be … and remove “financial uncertainty,” Novavax said in its earnings … In February 2023, when Novavax reported its 2022 financials, the …

  • Novavax settles dispute with Gavi 23 Feb 2024 07:17 GMT

    … vaccine. Novavax, which launched its vaccine after several competitors due to … deals," he added. Novavax has said that pending … terms of the settlement, Novavax has made an initial payment … $80 million a year, Novavax will provide an additional vaccine …

  • Novavax settles dispute with international vaccine group Gavi 22 Feb 2024 13:09 GMT

    … vaccine. Novavax, which launched its vaccine after several competitors due … he added. Last year, Novavax raised doubts about its ability … terms of the settlement, Novavax has made an initial payment … 80 million a year, Novavax will provide an additional vaccine …

  • JPM24, Day 2: Lilly CEO says competition benefits obesity field; Novavax readies phase 3 combo trial 09 Jan 2024 15:40 GMT

    … :09 p.m. ET Novavax is in discussions with Walgreens … the mRNA options.  Meanwhile, Novavax is in the latter half … government contracts and existing receivables. Novavax reported having $666 million … that Novo is the first competitor Lilly thinks about, but …

  • Novavax, Inc. (NASDAQ:NVAX) Q3 2023 Earnings Call Transcript 10 Nov 2023 19:02 GMT

    … Call Transcript November 9, 2023 Novavax, Inc. beats earnings expectations … relating to the future of Novavax, its key strategic priorities … several weeks after the competitor vaccines, we have limited … lifts in awareness of Novavax. The HCP aided awareness …

  • Novavax Unveils Plan to Cut Costs by Another $300 Million 09 Nov 2023 17:22 GMT

    … demand for its shots. Novavax already announced a restructuring plan … to reduce 2024 expenses, Novavax Chief Executive Officer John C … amid a rocky rollout of competitors’ offerings. Unlike Pfizer Inc … the creation of antibodies, Novavax’s shot stimulates the …

  • What’s next for COVID dark horse Novavax? 30 Oct 2023 13:45 GMT

    … , BioNTech, Moderna, and Novavax saw their stock prices drop … -19 vaccinations, but Novavax brings a differentiator with … , Novavax remains an underdog, competing against more established competitors with … offering more runway for Novavax. According to the FDA, …

  • Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far 16 Oct 2023 17:22 GMT

    … around the country, one more competitor has joined the mix. In … B vaccine. The company Novavax produces the protein in moth … than mammalian cells. The Novavax jab also includes a proprietary … don’t have that for Novavax,” Poland says. Manufacturing issues …

  • Novavax Covid Booster Gets FDA Nod 03 Oct 2023 20:11 GMT

    … amid a rocky rollout of competitors’ offerings. The vaccine is … the XBB variant this fall,” Novavax said in a statement. … the creation of antibodies, Novavax’s stimulates the immune system … , an executive vice president at Novavax, said in an interview. …

Satisfied with the content?

Continue to create your account.